SMTL ID : 4u6q.1

CtBP1 bound to inhibitor 2-(hydroxyimino)-3-phenylpropanoic acid

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

homo-dimer

Ligands

2 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)

NAI.1: 28 residues within 4Å: Chain A: S.94, G.95, T.122, I.174, G.175, G.177, R.178, V.179, Y.197, D.198, P.199, Y.200, L.201, H.230, C.231, G.232, N.234, N.237, L.240, T.258, A.259, R.260, D.284, V.285, H.309, A.311, W.312 Ligands: 3CR.2 21 PLIP interactions: 21 interactions with chain A Hydrophobic interactions: A:W.312 Hydrogen bonds: A:R.178, A:R.178, A:V.179, A:C.231, A:G.232, A:N.234, A:N.237, A:D.284, A:D.284, A:A.311, A:W.312 Water bridges: A:S.94, A:D.97, A:G.177, A:G.180, A:Y.197, A:L.233, A:H.236 Salt bridges: A:R.178 pi-Stacking: A:Y.200 NAI.5: 28 residues within 4Å: Chain B: S.94, G.95, T.122, I.174, G.175, G.177, R.178, V.179, Y.197, D.198, P.199, Y.200, L.201, H.230, C.231, G.232, N.234, N.237, L.240, T.258, A.259, R.260, D.284, V.285, H.309, A.311, W.312 Ligands: 3CR.6 22 PLIP interactions: 22 interactions with chain B Hydrophobic interactions: B:W.312 Hydrogen bonds: B:R.178, B:R.178, B:V.179, B:C.231, B:G.232, B:N.234, B:N.237, B:D.284, B:A.311, B:W.312 Water bridges: B:S.94, B:D.97, B:G.177, B:G.180, B:Y.197, B:Y.197, B:Y.200, B:Y.200, B:L.233 Salt bridges: B:R.178 pi-Stacking: B:Y.200

2 x 3CR: (2E)-2-(hydroxyimino)-3-phenylpropanoic acid(Non-covalent)

3CR.2: 12 residues within 4Å: Chain A: Y.70, H.71, R.91, I.92, G.93, S.94, G.95, R.260, H.309, W.312, M.321 Ligands: NAI.1 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:Y.70, A:W.312, A:W.312 Hydrogen bonds: A:S.94, A:S.94, A:G.95 Salt bridges: A:R.91, A:R.260, A:H.309 pi-Stacking: A:W.312, A:W.312 3CR.6: 12 residues within 4Å: Chain B: Y.70, H.71, R.91, I.92, G.93, S.94, G.95, R.260, H.309, W.312, M.321 Ligands: NAI.5 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:Y.70, B:W.312, B:W.312 Hydrogen bonds: B:S.94, B:S.94, B:G.95 Salt bridges: B:R.91, B:R.260, B:H.309 pi-Stacking: B:W.312, B:W.312

2 x CA: CALCIUM ION(Non-functional Binders)

CA.3: 1 residues within 4Å: Ligands: FMT.4 No protein-ligand interaction detected (PLIP) CA.7: 1 residues within 4Å: Ligands: FMT.8 No protein-ligand interaction detected (PLIP)

2 x FMT: FORMIC ACID(Non-functional Binders)

FMT.4: 6 residues within 4Å: Chain A: E.169, D.225, G.252, F.254, R.279 Ligands: CA.3 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Y.134, A:E.169 Water bridges: A:R.279, A:R.279, A:R.279 FMT.8: 6 residues within 4Å: Chain B: E.169, D.225, G.252, F.254, R.279 Ligands: CA.7 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:E.169 Water bridges: B:D.225, B:R.279, B:R.279, B:R.279

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hilbert, B.J. et al., Structure-Guided Design of a High Affinity Inhibitor to Human CtBP. Acs Chem.Biol. (2015)

Release Date

2015-02-11

Peptides

C-terminal-binding protein 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C-terminal-binding protein 1

Related Entries With Identical Sequence